Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
Search
Jan 12, 2024
Interoperable Telehealth: Patient Safety Considerations
As efforts to connect patients and providers through telehealth continue, new delivery challenges have become apparent.
February 24, 2025, Insurance Insider US
Nuclear Medmal Verdicts: Is $50mn the New $25mn?
Rick Soulsby, Senior Vice President and Chief Actuary, The Doctors Company, part of TDC Group, provides insights into how medical malpractice awards are doubling in size from pre-pandemic years.
April 01, 2025, Healthcare Risk Management
Avoid the Common Pitfalls in Medical Documentation
Daniel Kent Cassavar, MD, MBA, FACC, Medical Director, The Doctors Company and TDC Group, discusses the importance of accurate and thorough healthcare documentation.
May 20, 2024, Part B News
Must You Rehire Suspended Providers Who Get Their License Back? Look to Contract
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides insight on how practices should respond when suspended providers get their licenses back.
January 22, 2024, Physicians Practice
Fulfilling the Growing Need for Primary Care
Laura Kline, MBA, CPCU, Senior Vice President, Business Development, The Doctors Company and TDC Group, discusses how advanced practice clinicians are part of the solution to addressing the physician shortage.
September 20, 2024, Medical Economics
Malpractice Caps and Nuclear Verdicts
Medical Economics Editorial Director Chris Mazzolini sits down with Bob White, President of The Doctors Company and TDC Group, to discuss trends in malpractice litigation and what recent verdicts mean for the industry at large.
March 05, 2024, Business Insurance
Alabama Embryo Ruling May Increase Med Mal Risks
Robert White, President of The Doctors Company and TDC Group, discusses the potential impacts the recent IVF ruling in Alabama will have on healthcare professionals.
November 28, 2023, Crico
Higher Malpractice Risk with Advanced Practice Providers? Data Say Not Really
Does the increased prevalence of non-physician patient care mean an increased risk to patient safety?
December 11, 2023, Part B News
Thwart Abuse: Consider Opt-out,Training in Chaperone Policy
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides policy suggestions for healthcare providers to implement that can help defend against sexual harassment allegations.
